continu fundament
momentum reiter buy
envis earn potenti base organ
growth compound-annual-growth-rate superior peer tranzact inclus
ebitda margin vs consensu sourc hcb
talent broadli destin employ believ multi-year
opportun refin crb segment margin higher revis ep
estim believ stock attract
ebitda low end broker group figur price target
repres target multipl appli forecast
report adjust ep line
street mean estim revenu billion
slightli consensu averag billion forecast
billion fx million headwind organ growth overal
similar last quarter one point better prior year
quarter adjust oper margin bp year
year improv seen oper segment exclud chang
pension-rel incom adjust ep would advanc year
year adjust tax rate estim
compani reiter full-year ep outlook rang
organ revenu growth outlook last quarter
guidanc rais primarili reflect
close tranzact acquisit particularli
accret season strong fourth quarter
gener million nine month lag last
year total million impact compens outlay
time tax payment
manag expect free cash flow growth
midpoint versu prior outlook growth
next three year lower expect attribut
higher cash tax less progress dso improv
transact cost tranzact werent includ origin
outlook said manag maintain guidanc
annual improv three year
tr target
human capit benefit hcb gener organ top-line growth million
estim million boost benefit due strong demand
analyt servic compani saw expans reward solid gain
local global appoint technolog administr solut saw
higher project demand western europ great britain retir revenu return growth
driven pension de-risk larg plan market
oper margin segment compar year-ago period
estim
corpor risk broke revenu rose organ momentum across
geographi particularli north america manag point
healthi renew along solid new busi win respect price manag describ
modest improv also indic outlook remain posit
crb oper margin gain point similar increas seen prior
quarter line forecast
organ growth invest risk reinsur irr bit softer
identifi progress reinsur underwrit capit manag
term new busi growth along renew revenu wltw also saw momentum insur
consult technolog sale revenu well max matthiessen
wholesal invest likewis posit territori
profit irr busi held steadi prior year quarter
forecast
benefit deliveri administr revenu million organ
forecast million compani growth function continu expans client
base rise demand mid-market large-market project work benefit outsourc
rel flat prior year revenu within benefit outsourc core servic offer
mute due time shift individu marketplac
tranzact oper part bda segment contribut segment
revenu quarter neg oper margin better neg
bda oper margin compar quarter last year note
compani gener earn fourth quarter within segment
later lesson buy suggest medicar advantag market
remain robust comparison platform firm gain market share revenu rose
yoy medicar approv member advanc well compar forecast
rate market growth per center medicar medicaid
servic time believ comparison shop platform like take share
manag care firm due opportun make better healthcar purchas
provid consum present major senior purchas directli carrier
view inher sub-optim sinc find best fit one carrier signifi
find best fit avail market hope gain insight upcom
visit ehth hq month
page
page
million except per share data
salari benefit
updat
requir disclosur last tab workbook
compani file strh estim
result restat use pro-forma result impact certain line item explicitli restat compani
price
page
advisori brokerag compani offer servic world-wide divid
oper four busi segment corpor risk broke exchang solut
capit benefit invest risk reinsur origin found base
london compani formerli known willi group hold plc chang name
januari acquir tower watson co
buy rate predic opinion compani continu drive margin expans
cost reduct top-lin growth cross-sel well expand health
exchang opportun given uncertainti space also believ compani benefit
short-term tailwind emerg interest cyber secur coverag earli client
win
valuat risk
price target current trade ev ebitda multipl
peer think financi out-performance next sever year could result multipl
expans cross-sel potenti view allow outperform
brokerag consult peer new experienc senior leadership team
price target assum stock trade next year ebitda
risk rate price target insur price may improv make difficult
compani gener posit organ growth addit tw risk includ declin
asset price could reduc amount pension benefit asset affect health
compani client signific decreas demand consult actuari servic
result chang econom condit factor may also affect stock
compani mention note
mark hugh herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
tobey sommer herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express specif
recommend report
